Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 10,
2017
Wound Management Technologies, Inc.
(Exact name of registrant as specified in its charter)
|
Texas
|
000-11808
|
59-2219994
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
16633 Dallas Parkway, Suite 250
Addison, Texas
(Address of principal
executive offices)
|
75001
(zip code)
|
|
Registrant’s telephone number, including area code: (972)
218-0935
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[
]
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[
]
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
]
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
[
]
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On
March 10, 2017, Wound Management Technologies, Inc. (the
“Company”) and John Siedhoff, the chairman of the
Company’s Board of Directors, entered into an amendment to
the Consulting Agreement, dated April 25, 2016, by and between the
Company and Mr. Siedhoff (the “Amendment”). The
Amendment: (i) changes the name of the consultant under the
Consulting Agreement from John Siedhoff to Twin Oaks Equities, LLC
(an entity controlled by Mr. Siedhoff), and (ii) increases the
monthly compensation payable under the Consulting Agreement from
$15,000 to $20,000, effective as of January 1, 2017.
Item 9.01. Financial Statements and Exhibits
(d)
Exhibits.
Exhibit.
Amendment to Consulting Agreement dated March 10, 2017, by
and between the Company
and John Siedhoff
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
Wound Management Technologies, Inc.
|
|
|
|
|
|
|
|
Date:
March 13, 2017
|
By:
|
/s/
Deborah Jenkins Hutchinson
|
|
|
|
|
|
|
|
|
|
|
|